E Geido
Overview
Explore the profile of E Geido including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
172
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Risio M, Geido E, Divinci A, Rapallo A, Pujic N, Rossini F, et al.
Int J Oncol
. 2011 May;
3(5):941-7.
PMID: 21573457
In order to better understand the relationship of DNA ploidy, dysplasia, early cancer, and colorectal tumor progression, 11 colorectal adenomas containing carcinoma invading the submucosa were investigated using DNA flow...
2.
Avignolo C, Nigro S, Geido E, Giaretti W
Int J Oncol
. 2011 May;
7(5):1213-7.
PMID: 21552953
N-(4-Hydroxyphenyl)retinamide (HPR) is a synthetic retinoid with anticancer properties and lower toxicity than all-trans retinoic acid (RA). We have studied the effects of HPR on apoptosis and differentiation in the...
3.
Giaretti W, Rapallo A, Sciutto A, Macciocu B, Geido E, Hermsen M, et al.
Anal Cell Pathol
. 2001 Apr;
21(2):49-57.
PMID: 11310641
The molecular pathways and the timing of genetic events during human colorectal carcinogenesis are still not fully understood. We have addressed the intratumor heterogeneity of the mutational status of the...
4.
Neri M, Geido E, Filiberti R, Orecchia R, Di Vinci A, Cafferata M, et al.
Anal Cell Pathol
. 2001 Mar;
21(1):35-40.
PMID: 11254223
The glycophoryn A (GPA) assay evaluates somatic in vivo mutations. It is considered a cumulative biodosimeter for genotoxic exposures and is under evaluation in cancer risk assessment. GPA, a polymorphic...
5.
Corvo R, Margarino G, Sanguineti G, Geido E, Scala M, Mereu P, et al.
Tumori
. 2000 Apr;
86(1):53-8.
PMID: 10778767
Background: The increasing complexity of management strategies for patients with head and neck squamous cell carcinoma (HN-SCC) calls for the investigation of new objective prognostic parameters to subdivide patients according...
6.
Corvo R, Paoli G, Giaretti W, Sanguineti G, Geido E, Benasso M, et al.
Int J Radiat Oncol Biol Phys
. 2000 Apr;
47(1):57-63.
PMID: 10758305
Purpose: The aim of this study was to investigate the potential clinical relevance of cell kinetics parameters to the locoregional control (LRC) and overall survival of patients affected by head...
7.
Orecchia R, Infusini E, Sciutto A, Rapallo A, Di Vinci A, Nigro S, et al.
J Pathol
. 2000 Mar;
190(4):423-9.
PMID: 10699990
Mutant ras genes occur frequently in human neoplasia and, in particular, in pancreatic, colorectal, and lung adenocarcinomas. Recent evidence suggests that G-->T and G-->C transversions of the Ki-ras gene in...
8.
Rapallo A, Sciutto A, Geido E, Orecchia R, Infusini E, Pujic N, et al.
Anal Cell Pathol
. 2000 Feb;
19(1):39-46.
PMID: 10661623
The possible role of K-ras2 mutations and aneuploidy toward increase of proliferation and adenoma size in Familial Adenomatous Polyposis (FAP) adenomas is not known. The present study addresses these issues...
9.
Caderni G, Dolara P, Fazi M, Luceri C, Geido E, Rapallo A, et al.
Oncol Rep
. 1999 Oct;
6(6):1417-20.
PMID: 10523722
Cell cycle variations and DNA aneuploidy, were investigated in different phases of azoxymethane (AOM)-induced colon carcinogenesis in rats by flow cytometry. K-ras gene mutations (transitions Gright curved arrow A) were...
10.
Di Vinci A, Infusini E, Peveri C, Sciutto A, Orecchia R, Geido E, et al.
Cytometry
. 1999 Apr;
35(4):369-75.
PMID: 10213203
Background: The origin and evolution of somatic chromosome aberrations in colorectal cancer is still poorly understood. The data in the literature suggest that some specific chromosome aberrations are more common....